Quigley, Chan, and Harris (social ethics and policy, U. of Manchester, UK) draw together 10 chapters by ethicists and legal scholars from the UK, Belgium, and Australia, who explore ethical, legal, and social issues and arguments related to the use of stem cells in research, the treatment of disease, and infertility. They review recent developments and debates, then address embryonic stem cells for research and clinical applications, including the concepts of moral status and the embryo as constructed; legal issues, namely the regulation of human stem cell technologies and the use of a legal property framework for human embryos created through in vitro fertilization but intended for research; ethical debates about the created-discarded distinction in human embryonic stem cell research, the notion of complicity, and claims of hypocrisy in research; and new developments in stem cell science and whether they require new considerations in ethical arguments, with discussion of the potential for stem cell research to facilitate same-sex reproduction and early stage clinical stem cell trials for spinal cord injury. Annotation ©2013 Book News, Inc., Portland, OR (booknews.com)
This book provides high quality chapters each of which deals with different aspects of the stem cell debate, each chapter, in itself, giving an in-depth and comprehensive analysis of its own particular issue (ethical or legal). The scope of this book ranges across a number of different issues in the debate on stem cells, from the ethical challenges of conducting stem cell research to those of the clinical application of stem cell technology.Fast-moving and ever-changing, stem cell science and research presents ongoing ethical and legal challenges in the UK as well as in many other countries. Each development and innovation throws up new ethical challenges. This is the case even where a new development, for example, induced pluripotent stem cells, initially seems to solve old dilemmas. Sometimes it becomes evident that new science does not in fact solve old problems and the ethical issues remain. In recognition of this, this book tackles these issues, old and new. The early chapters bring fresh new perspectives on the permissibility of using embryos in stem cell research, while the later chapters move on to actual and potential new clinical uses of stem cells and present novel arguments about this. The value of this approach is that readers can gain an understanding of the different issues in the stem cell debate from a number of ethical (and legal) perspectives, but in a manner which gives deep and rigorous analysis.